Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Recent treatment strategies and molecular pathways in resistance mechanisms of antiangiogenic therapies in glioblastoma
MA Rahman, MM Ali - Cancers, 2024 - mdpi.com
Simple Summary Glioblastoma (GBM) appears to be a challenging malignancy to
completely eradicate, with few significant improvements in treatment. This review explores …
completely eradicate, with few significant improvements in treatment. This review explores …
[HTML][HTML] Global research progress of nanomedicine and colorectal cancer: a bibliometrics and visualization analysis
S Tian, M Chen - Frontiers in Oncology, 2024 - pmc.ncbi.nlm.nih.gov
Background Surgery and chemoradiotherapy are the main clinical treatment methods for
colorectal cancer (CRC), but the prognosis is poor. The emergence of nanomedicine brings …
colorectal cancer (CRC), but the prognosis is poor. The emergence of nanomedicine brings …
[HTML][HTML] MiRNA-155: A double-edged sword in colorectal cancer progression and drug resistance mechanisms
Colorectal cancer (CRC) is a leading cause of death worldwide due to its aggressive nature
and drug resistance, which limit traditional treatment effectiveness. Recent studies highlight …
and drug resistance, which limit traditional treatment effectiveness. Recent studies highlight …
Advances in polymer-centric nanomedicines for theranostic cancer treatment
A Bag, R Maheshwari - Journal of Drug Delivery Science and Technology, 2024 - Elsevier
A potentially fatal illness, cancer claims the lives of millions of people worldwide.
Nanomedicine is one type of medical treatment that is always becoming more and more …
Nanomedicine is one type of medical treatment that is always becoming more and more …
[HTML][HTML] New Insights into Mucosa-Associated Microbiota in Paired Tumor and Non-Tumor Adjacent Mucosal Tissues in Colorectal Cancer Patients
A González, A Fullaondo, D Navarro, J Rodríguez… - Cancers, 2024 - mdpi.com
Abstract Background/Objective: Colorectal cancer (CRC) is one of the most common
cancers worldwide. Increasing scientific evidence supports the idea that gut microbiota …
cancers worldwide. Increasing scientific evidence supports the idea that gut microbiota …
LncRNA CCAT2 promotes the proliferation and metastasis of colorectal cancer through activation of the ERK and Wnt signaling pathways by regulating GNB2 …
J Tian, X Cao, Z Jiang, J Wang, W Fan… - Cancer …, 2024 - Wiley Online Library
Background Colorectal cancer (CRC) is a prevalent and lethal tumor, with metastasis being
the leading cause of mortality. Previous research has indicated that the long non‐coding …
the leading cause of mortality. Previous research has indicated that the long non‐coding …
[HTML][HTML] Liquid biopsy in cancer management: Integrating diagnostics and clinical applications
S Pandey, P Yadav - Practical Laboratory Medicine, 2024 - Elsevier
Liquid biopsy is an innovative, minimally invasive diagnostic tool revolutionizing cancer
management by enabling the detection and analysis of cancer-related biomarkers from …
management by enabling the detection and analysis of cancer-related biomarkers from …
Nanotechnology-Driven Approaches for Targeted Rectal Microbiome Modulation in Gastrointestinal Disorders
K Dudhat - Current Proteomics, 2025 - benthamdirect.com
The gastrointestinal tract hosts a complex ecosystem of microorganisms, with rectum playing
a critical role in microbial diversity and health. This manuscript provides a comprehensive …
a critical role in microbial diversity and health. This manuscript provides a comprehensive …
Host genetics-associated mechanisms in colorectal cancer.
A González, A Fullaondo, A Odriozola - Advances in Genetics, 2024 - europepmc.org
Colorectal cancer (CRC) represents the second leading cause of cancer incidence and the
third leading cause of cancer deaths worldwide. There is currently a lack of understanding of …
third leading cause of cancer deaths worldwide. There is currently a lack of understanding of …
Personalised medicine based on host genetics and microbiota applied to colorectal cancer
A González, I Badiola, A Fullaondo… - Advances in …, 2024 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) ranks second in incidence and third in cancer mortality worldwide.
This situation, together with the understanding of the heterogeneity of the disease, has …
This situation, together with the understanding of the heterogeneity of the disease, has …